Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday:
View full multimedia release here. (Rye Brook, NY – May 3, 2017) – The nation’s leading experts on blood cancers and healthcare policy convened yesterday in Washington, D.C. to discuss the ever-increasing cost barriers that patients and their families face to access high-quality care, as well as discuss cutting-edge blood cancer research and treatments. The event was organized by The Leukemia & Lymp...
(Rye Brook, NY – May 2, 2017) – The rising cost of treatment and care for blood cancer patients has reached a boiling point, according to The Leukemia & Lymphoma Society (LLS), with an increasing number of patients foregoing their medications or reducing the dosage or frequency of their doctor‐prescribed treatments solely for cost reasons. In 2016, LLS’s free Information Resource Center received more than...
View full multimedia release here (Washington, D.C., May 3, 2017) – The Leukemia & Lymphoma Society (LLS) and the SAGERSTRONG Foundation announced yesterday they are teaming up to raise funds to fight blood cancers, the third leading cause of cancer deaths in the United States. Louis J. DeGennaro, Ph.D., LLS president and CEO, and Stacy Sager, president of the SAGERSTRONG Foundation, jointly made the announc...
The Leukemia & Lymphoma Society (LLS) firmly opposes the Administration’s proposed budget, which reduces the funding for the National Institutes of Health (NIH) by $5.8 billion. These cuts risk derailing decades of advancement in the diagnosis, understanding and treatment of deadly blood cancers. LLS is calling upon members of Congress to reject these proposed cuts and increase funding for the NIH in future app...